Search research articles
Contact Us
Filters
Showing results (81-90 of 134) with videos related to
Page
of 14
Sort By:
Journal of Multimorbidity and Comorbidity
|
April 7, 2025
Multimorbidity frameworks impact the composition of patterns and their associations with patient-reported outcomes among people with HIV
Luxsena Sukumaran, Alan Winston, Jane Anderson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 15, 2008
Evaluation of filter paper transfer of whole-blood and plasma samples for quantifying HIV RNA in subjects on antiretroviral therapy in Uganda
Laura Waters, Andrew Kambugu, Hilda Tibenderana, et al.
AIDS (London, England)
|
June 6, 2025
Changes in multimorbidity burden and their impact on patient and healthcare outcomes in people with HIV over a 3-5-year period
Luxsena Sukumaran, Alan Winston, Frank A Post, et al.
Clinical Pharmacology and Therapeutics
|
May 14, 2022
Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications
Catia Marzolini, Daniel R Kuritzkes, Fiona Marra, et al.
Virology Journal
|
February 10, 2025
Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed adults with nucleos(t)ide analogue resistance- a phase IV randomised, open-label study (PIBIK study)
Collins Iwuji, Laura Waters, Ana Milinkovic, et al.
AIDS (London, England)
|
October 1, 2019
No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIV
James E Burns, Oliver T Stirrup, David Dunn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 19, 2025
Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practice
Flora Olcott, Philip D Oddie, Maeve J Barlow, et al.
AIDS (London, England)
|
December 30, 2025
Associations between plasma biomarkers and changes in cognitive function over two years in people with and without HIV
Jasmini Alagaratnam, Nicholas Bakewell, Ken M Kunisaki, et al.
HIV Medicine
|
March 19, 2026
Missed opportunities to prevent HIV acquisition with pre-exposure prophylaxis: A mixed methods study of people with recently acquired HIV in the United Kingdom
Argyro Karakosta, Emily Jay Nicholls, Flavien Coukan, et al.
The Lancet. Infectious Diseases
|
July 9, 2022
Outbreak of sexually transmitted, extensively drug-resistant Shigella sonnei in the UK, 2021-22: a descriptive epidemiological study
Hannah Charles, Mateo Prochazka, Katie Thorley, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 134) with videos related to
Sort By:
Page
of 14
Journal of Multimorbidity and Comorbidity
|
April 7, 2025
Multimorbidity frameworks impact the composition of patterns and their associations with patient-reported outcomes among people with HIV
Luxsena Sukumaran, Alan Winston, Jane Anderson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 15, 2008
Evaluation of filter paper transfer of whole-blood and plasma samples for quantifying HIV RNA in subjects on antiretroviral therapy in Uganda
Laura Waters, Andrew Kambugu, Hilda Tibenderana, et al.
AIDS (London, England)
|
June 6, 2025
Changes in multimorbidity burden and their impact on patient and healthcare outcomes in people with HIV over a 3-5-year period
Luxsena Sukumaran, Alan Winston, Frank A Post, et al.
Clinical Pharmacology and Therapeutics
|
May 14, 2022
Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications
Catia Marzolini, Daniel R Kuritzkes, Fiona Marra, et al.
Virology Journal
|
February 10, 2025
Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed adults with nucleos(t)ide analogue resistance- a phase IV randomised, open-label study (PIBIK study)
Collins Iwuji, Laura Waters, Ana Milinkovic, et al.
AIDS (London, England)
|
October 1, 2019
No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIV
James E Burns, Oliver T Stirrup, David Dunn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 19, 2025
Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practice
Flora Olcott, Philip D Oddie, Maeve J Barlow, et al.
AIDS (London, England)
|
December 30, 2025
Associations between plasma biomarkers and changes in cognitive function over two years in people with and without HIV
Jasmini Alagaratnam, Nicholas Bakewell, Ken M Kunisaki, et al.
HIV Medicine
|
March 19, 2026
Missed opportunities to prevent HIV acquisition with pre-exposure prophylaxis: A mixed methods study of people with recently acquired HIV in the United Kingdom
Argyro Karakosta, Emily Jay Nicholls, Flavien Coukan, et al.
The Lancet. Infectious Diseases
|
July 9, 2022
Outbreak of sexually transmitted, extensively drug-resistant Shigella sonnei in the UK, 2021-22: a descriptive epidemiological study
Hannah Charles, Mateo Prochazka, Katie Thorley, et al.
Page
of 14